Platelet-rich auto plasma in the treatment of inflammatory periodontal disease

Abstract

The success of treatment with generally accepted methods is extremely low, often the transition of acute inflammatory processes to subacute and chronic occurs, and recovery processes are difficult. Medical treatment of periodontitis remains the main and at the present time. This pathology is extremely difficult to treat, and it is almost impossible to eliminate the further development of the disease, which requires the introduction of new methods of treatment in dental practice. At present, periodontics are showing great interest in the use of platelet autoplasma (TAP) in the treatment of periodontal tissue lesions, which received the original name Plasmolifting ™. Given the widespread prevalence of inflammatory diseases of periodontal tissues and the adverse effect on the body as a whole, there is a need to develop new both diagnostic and therapeutic complexes that could help the doctor recognize the etiological and pathogenetic factors of the disease, as well as conduct their correction at the initial stage of the onset of the disease. It is important to note that Plasmolifting ™ technology does not require the use of calcium chloride and double centrifugation, while remaining as efficient, convenient and safe as possible. Platelet autologous plasma has several useful properties: it accelerates tissue regeneration, has an anti-inflammatory effect, and reduces pain, which opens up great prospects for its use in dentistry. This problem remains unresolved, since studies demonstrating the use of platelet autoplasma in the treatment of periodontitis are currently insufficient to understand the principle of its action. In connection with the above arguments, the solution of the above problems by performing the planned research work is timely and relevant.